Cancer Research The Future of Cancer Research: Science and Patient Impact  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 39, 2505-2509, July 1, 1979]
© 1979 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hoffmann, D.
Right arrow Articles by Hecht, S. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hoffmann, D.
Right arrow Articles by Hecht, S. S.

Assessment of Tobacco-specific N-Nitrosamines in Tobacco Products1

Dietrich Hoffmann2, John D. Adams, Klaus D. Brunnemann and Stephen S. Hecht3

Division of Environmental Carcinogenesis, Naylor Dana Institute for Disease Prevention, American Health Foundation, Valhalla, New York 10595

Tobacco-specific nonvolatile N-nitrosamines in tobacco and in fresh mainstream and sidestream smoke of cigarettes and cigars were quantitatively determined with a thermal energy analyzer. The smoke was trapped in ascorbic acid solution buffered at pH 4.5 and extracted with dichloromethane, and the organic phase was chromatographed and analyzed by high-performance liquid chromatography-thermal energy analyzer methodology (sensitivity, 250 pg/injection). The nonvolatile nitrosamines were further enriched by repeated chromatography and positively identified by gas-liquid chromatography-mass spectrometry. [2'-14C]N'-nitrosonornicotine served as internal standard for the quantitative analysis.

The tobacco of five different cigarettes contained between 0.22 and 7.0 ppm of the carcinogenic N'-nitrosonornicotine, 0.13 and 0.74 ppm of the carcinogenic 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone, and 0.44 to 3.2 ppm of the newly identified N'-nitrosoanatabine. In unaged mainstream and sidestream smoke of the same cigarettes, values ranged between 0.24 and 3.7 and 0.15 and 6.1 µg/cigarette for N'-nitrosonornicotine, between 0.11 and 0.42 and 0.19 and 0.66 µg/cigarette for 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone, and between 0.33 and 4.6 and 0.15 and 1.5 µg/cigarette for N'-nitrosoanatabine, respectively. The relatively high concentrations of these carcinogenic N-nitrosamines in sidestream smoke are discussed as possible tobacco-specific indicators for indoor pollution.

1 Supported by National Cancer Institute Contract NO1-CP-55666 and American Cancer Society Grant BC56, The Alexander Ralston Peacock Memorial Grant. This is Paper 62 in the series, "Chemical Studies on Tobacco Smoke."

2 To whom requests for reprints should be addressed, at Division of Environmental Carcinogenesis, Naylor Dana Institute for Disease Prevention, Dana Road, American Health Foundation, Valhalla, N. Y. 10595.

3 Recipient of National Cancer Institute Research Career Development Award NO-5K04CA00124.

Received 1/11/79. Accepted 4/ 3/79.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1979 by the American Association for Cancer Research.